The Gene Curation Coalition: A global effort to harmonize gene-disease evidence resources.

Database GenCC Gene curation Genetic diagnosis The Gene Curation Coalition

Journal

Genetics in medicine : official journal of the American College of Medical Genetics
ISSN: 1530-0366
Titre abrégé: Genet Med
Pays: United States
ID NLM: 9815831

Informations de publication

Date de publication:
08 2022
Historique:
received: 30 12 2021
revised: 06 04 2022
accepted: 07 04 2022
pubmed: 5 5 2022
medline: 11 8 2022
entrez: 4 5 2022
Statut: ppublish

Résumé

Several groups and resources provide information that pertains to the validity of gene-disease relationships used in genomic medicine and research; however, universal standards and terminologies to define the evidence base for the role of a gene in disease and a single harmonized resource were lacking. To tackle this issue, the Gene Curation Coalition (GenCC) was formed. The GenCC drafted harmonized definitions for differing levels of gene-disease validity on the basis of existing resources, and performed a modified Delphi survey with 3 rounds to narrow the list of terms. The GenCC also developed a unified database to display curated gene-disease validity assertions from its members. On the basis of 241 survey responses from the genetics community, a consensus term set was chosen for grading gene-disease validity and database submissions. As of December 2021, the database contained 15,241 gene-disease assertions on 4569 unique genes from 12 submitters. When comparing submissions to the database from distinct sources, conflicts in assertions of gene-disease validity ranged from 5.3% to 13.4%. Terminology standardization, sharing of gene-disease validity classifications, and resolution of curation conflicts will facilitate collaborations across international curation efforts and in turn, improve consistency in genetic testing and variant interpretation.

Identifiants

pubmed: 35507016
pii: S1098-3600(22)00746-8
doi: 10.1016/j.gim.2022.04.017
pmc: PMC7613247
mid: EMS144755
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1732-1742

Subventions

Organisme : NHGRI NIH HHS
ID : U24 HG006834
Pays : United States
Organisme : British Heart Foundation
ID : RE/18/4/34215
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UP_1102/20
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 208349
Pays : United Kingdom
Organisme : NHGRI NIH HHS
ID : U24 HG003345
Pays : United States
Organisme : Wellcome Trust
Pays : United Kingdom

Informations de copyright

Copyright © 2022 American College of Medical Genetics and Genomics. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of Interest R.E.F. is an employee of SciBite Ltd, an Elsevier company. Her work toward this paper was performed when she was employed by Genomics England. The following authors are employees for a commercial laboratory that offers clinical genetic testing: M.B., A.J.C., K.R., J.T. All other authors declare no conflicts of interest.

Auteurs

Marina T DiStefano (MT)

Geisinger Health System, Danville, PA; Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA.

Scott Goehringer (S)

Geisinger Health System, Danville, PA.

Lawrence Babb (L)

Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA.

Fowzan S Alkuraya (FS)

Department of Translational Genomics, Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.

Joanna Amberger (J)

Online Mendelian Inheritance in Man (OMIM), Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.

Mutaz Amin (M)

INSERM, US14 - Orphanet, Paris, France.

Christina Austin-Tse (C)

Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA; Department of Pathology, Massachusetts General Hospital, Boston, MA; Mass General Brigham Laboratory for Molecular Medicine, Cambridge, MA.

Marie Balzotti (M)

Myriad Women's Health, San Francisco, CA.

Jonathan S Berg (JS)

Department of Genetics, UNC School of Medicine, University of North Carolina, Chapel Hill, NC.

Ewan Birney (E)

European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom.

Carol Bocchini (C)

Online Mendelian Inheritance in Man (OMIM), Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.

Elspeth A Bruford (EA)

HUGO Gene Nomenclature Committee (HGNC), European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom; Department of Haematology, School of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom.

Alison J Coffey (AJ)

Illumina Clinical Services Laboratory, Illumina Inc, San Diego, CA.

Heather Collins (H)

National Library of Medicine, Bethesda, MD; ICF International Inc, Fairfax, VA.

Fiona Cunningham (F)

Genome Interpretation, Genome Assembly and Annotation (GAA), European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom.

Louise C Daugherty (LC)

Genomics England, Queen Mary University of London, London, United Kingdom; Healx Ltd, Cambridge, United Kingdom.

Yaron Einhorn (Y)

Franklin by Genoox, Palo Alto, CA.

Helen V Firth (HV)

Department of Medical Genetics, Addenbrooke's Treatment Centre, Cambridge University Hospitals NHS Trust, Cambridge, United Kingdom.

David R Fitzpatrick (DR)

MRC Human Genetics Unit, MRC Institute of Genetics and Cancer, College of Medicine & Veterinary Medicine, The University of Edinburgh, Edinburgh, United Kingdom.

Rebecca E Foulger (RE)

Genomics England, Queen Mary University of London, London, United Kingdom; SciBite Limited, BioData Innovation Centre, Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom.

Jennifer Goldstein (J)

Department of Genetics, UNC School of Medicine, University of North Carolina, Chapel Hill, NC.

Ada Hamosh (A)

Online Mendelian Inheritance in Man (OMIM), Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.

Matthew R Hurles (MR)

Wellcome Sanger Institute, Hinxton, United Kingdom.

Sarah E Leigh (SE)

Genomics England, Queen Mary University of London, London, United Kingdom.

Ivone U S Leong (IUS)

Genomics England, Queen Mary University of London, London, United Kingdom.

Sateesh Maddirevula (S)

Department of Translational Genomics, Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.

Christa L Martin (CL)

Geisinger Health System, Danville, PA.

Ellen M McDonagh (EM)

Genomics England, Queen Mary University of London, London, United Kingdom; Open Targets, EMBL-EBI, Wellcome Genome Campus, Hinxton, Cambridgeshire, United Kingdom.

Annie Olry (A)

INSERM, US14 - Orphanet, Paris, France.

Arina Puzriakova (A)

Genomics England, Queen Mary University of London, London, United Kingdom.

Kelly Radtke (K)

AmbryGenetics, Aliso Viejo, CA.

Erin M Ramos (EM)

National Human Genome Research Institute, National Institutes of Health Bethesda, MD.

Ana Rath (A)

INSERM, US14 - Orphanet, Paris, France.

Erin Rooney Riggs (ER)

Autism & Developmental Medicine Institute, Geisinger, Danville, PA.

Angharad M Roberts (AM)

National Heart and Lung Institute & MRC London Institute of Medical Sciences, Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, United Kingdom; Great Ormond Street Hospital, London, United Kingdom.

Charlotte Rodwell (C)

INSERM, US14 - Orphanet, Paris, France.

Catherine Snow (C)

Genomics England, Queen Mary University of London, London, United Kingdom.

Zornitza Stark (Z)

Australian Genomics, Melbourne, Australia.

Jackie Tahiliani (J)

Invitae, San Francisco, CA.

Susan Tweedie (S)

HUGO Gene Nomenclature Committee (HGNC), European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom.

James S Ware (JS)

Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA; National Heart and Lung Institute & MRC London Institute of Medical Sciences, Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, United Kingdom; Royal Brompton & Harefield Hospitals, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.

Phillip Weller (P)

Autism & Developmental Medicine Institute, Geisinger, Danville, PA.

Eleanor Williams (E)

Genomics England, Queen Mary University of London, London, United Kingdom.

Caroline F Wright (CF)

Institute of Biomedical and Clinical Science, University of Exeter Medical School, Royal Devon & Exeter Hospital, Exeter, United Kingdom.

Thabo Michael Yates (TM)

MRC Human Genetics Unit, MRC Institute of Genetics and Cancer, College of Medicine & Veterinary Medicine, The University of Edinburgh, Edinburgh, United Kingdom.

Heidi L Rehm (HL)

Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA; Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA. Electronic address: HREHM@mgh.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH